Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 17 August 2010
Vol. 3, Issue 135, p. re5
[DOI: 10.1126/scisignal.3135re5]


Phosphatidylinositol 3-Kinase Signaling in Thymocytes: The Need for Stringent Control

Elisabeth Fayard1*, Gerald Moncayo1, Brian A. Hemmings1*, and Georg A. Holländer2

1 Friedrich Miescher Institute for Biomedical Research, Maulbeerstrasse 66, CH-4058 Basel, Switzerland.
2 Pediatric Immunology, Center for Biomedicine, Department of Clinical-Biological Sciences, The University of Basel and The University Children’s Hospital, Mattenstrasse 28, CH-4058 Basel, Switzerland.

Gloss: The immune system is composed of the closely interacting innate and adaptive effector systems, and it serves to eliminate almost all types of pathogens as well as some malignancies. Whereas the innate arm of the immune system provides an immediate, but nonspecific, form of defense against pathogens, it is the system’s adaptive response, which is mediated by B and T lymphocytes, that assures antigen specificity and immunological memory, albeit after a delay of several days. The vast majority of T cells are formed in the thymus, which provides cell-surface and soluble ligands that are essential for T lineage commitment and differentiation. Among the pathways that are important for the de novo formation of T cells, signals that engage phosphatidylinositol 3-kinases (PI3Ks) are of particular importance, which is a finding consistent with a physiological role of PI3K signaling in cell differentiation in many different tissues. Moreover, uncontrolled activation of PI3K in thymocytes is associated with the formation of tumors, which highlights the requirement for a precise control of PI3K activity. In this Review, including two figures and 174 references, we discuss the importance of the PI3K-phosphoinositide–dependent protein kinase (PDK1)–protein kinase B (PKB) signaling pathway for the development of both normal and malignant thymocytes, and we outline the potential to target this pathway for therapeutic interventions.

* Corresponding authors. E-mail: brian.hemmings{at} (B.A.H.); elisabeth.fayard{at} (E.F.)

Citation: E. Fayard, G. Moncayo, B. A. Hemmings, G. A. Holländer, Phosphatidylinositol 3-Kinase Signaling in Thymocytes: The Need for Stringent Control. Sci. Signal. 3, re5 (2010).

Transition from Heterotypic to Homotypic PDK1 Homodimerization Is Essential for TCR-Mediated NF-{kappa}B Activation.
J.-A. Kang, S. P. Jeong, D. Park, M. S. Hayden, S. Ghosh, and S.-G. Park (2013)
J. Immunol. 190, 4508-4515
   Abstract »    Full Text »    PDF »
KAP1 regulates gene networks controlling T-cell development and responsiveness.
F. R. Santoni de Sio, I. Barde, S. Offner, A. Kapopoulou, A. Corsinotti, K. Bojkowska, R. Genolet, J. H. Thomas, I. F. Luescher, D. Pinschewer, et al. (2012)
FASEB J 26, 4561-4575
   Abstract »    Full Text »    PDF »
The Novel Therapeutic Effect of Phosphoinositide 3-Kinase-{gamma} Inhibitor AS605240 in Autoimmune Diabetes.
J. Azzi, R. F. Moore, W. Elyaman, M. Mounayar, N. El Haddad, S. Yang, M. Jurewicz, A. Takakura, A. Petrelli, P. Fiorina, et al. (2012)
Diabetes 61, 1509-1518
   Abstract »    Full Text »    PDF »
Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases.
O. Vadas, J. E. Burke, X. Zhang, A. Berndt, and R. L. Williams (2011)
Science Signaling 4, re2
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882